HITOX 200U Stabilized Neurotoxin Complex (200 Units/Vial)

HITOX 200U Clinical Specification Purified neurotoxin complex (900kDa) derived from Clostridium botulinum Hall strain. KFDA-approved clinical equivalence. ISO 13485:2016 certified biomanufacturing facility. FOR MEDICAL PROFESSIONALS ONLY Pharmacokinetics Onset: 72-120 hours post-administration Peak Efficacy: 14 days Duration: 16-24 weeks (dose-dependent) Diffusion: 0.6-1.2cm² target radius 99.8% Integrity Biochemical Profile Active Toxin: 200 Units Botulinum Toxin Type A (900kDa) Excipient 1: 0.5mg Pharmaceutical-Grade Human Serum Albumin (HSA) Excipient 2: 0.9mg Sodium Chloride (Isotonic Buffer) Immunogenicity: ≤0.1% resistance risk in Phase III trials Vacuum-Drying Stabilization Proprietary lyophilization methodology ensures residual moisture remains